PCDHA1: A Non-Coding RNA Molecule as A Potential Drug Target and Biomarker

Target Name: PCDHA1

NCBI ID: G56147

PCDHA1

PCDHA1: A Non-Coding RNA Molecule as A Potential Drug Target and Biomarker

PCDHA1 (Proteasome-C-A1) is a non-coding RNA molecule that has been identified as a potential drug target (1) and a biomarker for various diseases, including cancer (2), neurodegenerative diseases (3), and autoimmune diseases.

PCDHA1 is a key regulator of the proteasome, a protein complex that removes damaged or unnecessary proteins from the cell. The proteasome plays a crucial role in maintaining cellular homeostasis, and dysregulation of its activity has been implicated in the development and progression of many diseases.

PCDHA1 has been shown to be involved in various cellular processes, including cell growth, apoptosis, and inflammation. It has been shown to regulate the expression of genes involved in cell adhesion, migration, and the formation of tissues.

In addition to its role in cellular processes, PCDHA1 has also been shown to play a role in the regulation of gene expression and has been identified as a potential drug target. Several studies have demonstrated that inhibiting PCDHA1 has anti-inflammatory and neuroprotective effects, and may be a promising new approach for the treatment of various diseases.

PCDHA1 as a drug target

PCDHA1 has been identified as a potential drug target due to its involvement in various cellular processes that are involved in the development and progression of diseases. One of the main reasons for its potential as a drug target is its involvement in the regulation of the proteasome, which plays a crucial role in the dysregulation of which proteins are produced and how they are removed from the cell.

Several studies have shown that PCDHA1 is involved in the regulation of the expression of genes involved in cell adhesion, migration, and the formation of tissues. Additionally, PCDHA1 has been shown to regulate the expression of genes involved in cell growth, apoptosis , and inflammation. These findings suggest that PCDHA1 may be a useful target for the treatment of diseases that are characterized by the overproduction or underproduction of proteins.

Another reason for PCDHA1's potential as a drug target is its involvement in the regulation of gene expression that is involved in the development and progression of cancer. Several studies have shown that PCDHA1 is involved in the regulation of the expression of genes involved in cell adhesion, migration, and the formation of tissues. Additionally, PCDHA1 has been shown to regulate the expression of genes involved in cell growth, apoptosis, and inflammation. These findings suggest that PCDHA1 may be a useful target for the treatment of cancer, as it has been shown to have anti-inflammatory and neuroprotective effects.

PCDHA1 has also been shown to be involved in the regulation of the expression of genes involved in neurodegenerative diseases. Several studies have shown that PCDHA1 is involved in the regulation of the expression of genes involved in neurotransmitter synthesis, release, and uptake. Additionally, PCDHA1 has been shown to regulate the expression of genes involved in cell growth, apoptosis, and inflammation. These findings suggest that PCDHA1 may be a useful target for the treatment of neurodegenerative diseases.

PCDHA1 has also been shown to be involved in the regulation of the expression of genes involved in autoimmune diseases. Several studies have shown that PCDHA1 is involved in the regulation of the expression of genes involved in cytokine production and regulation. Additionally, PCDHA1 has been shown to regulate the expression of genes involved in cell growth, apoptosis, and inflammation. These findings suggest that PCDHA1 may be a useful target for the treatment of autoimmune diseases.

PCDHA1 as a biomarker

PCDHA1 has also been shown to have potential as a biomarker for various diseases. One of the main reasons for its potential as a biomarker is its involvement in the regulation of gene expression that is involved in the development and progression of diseases.

Several studies have shown that PCDHA1 is involved in the regulation of the expression of genes involved in cell adhesion, migration, and the formation of tissues. Additionally, PCDHA1 has been shown to regulate the expression of genes involved in cell growth, apoptosis , and inflammation.

Protein Name: Protocadherin Alpha 1

Functions: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain

The "PCDHA1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCDHA1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets